Inhibition of long-term potentiation by interleukin-8: Implications for human immunodeficiency virus-1-associated dementia

Journal of Neuroscience Research

Volumn 71, Issue 4, 2003, Pages 600-607

  Xiong, Huangui ^a,b   Boyle, Jeffery ^a   Winkelbauer, Matthew ^a   Gorantla, Santhi ^a,b   Zheng, Jialin ^a,b   Ghorpade, Anuja ^a,b   Persidsky, Yuri ^a,b   Carlson, Kimberly A ^a,b   Gendelman, Howard E ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

AIDS; Brain slices; Chemokine; Hippocampus

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 8; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CONTROLLED STUDY; DEMENTIA; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM POTENTIATION; MALE; MONOCYTE; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AIDS DEMENTIA COMPLEX; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; HIV-1; HUMANS; INTERLEUKIN-8; LONG-TERM POTENTIATION; MALE; MONOCYTES; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037441556     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10503     Document Type: Article

References (52)

1. Anderson E, Zink W, Xiong H, Gendelman HE. 2002. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. JAIDS 31:S43-S54.
2. Araujo DM, Cotman CW. 1993. Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res 600:49-55.
3. Baggiolini M, Walz A, Kunkel SL. 1989. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049.
4. Bliss TV, Collingridge GL. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39.
5. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335:639-642.
6. Coughlan CM, McManus CM, Sharron M, Gao Z, Murphy D, Jaffer S, Choe W, Chen W, Hesselgesser J, Gaylord H, Kalyuzhny A, Lee VM, Wolf B, Doms RW, Kolson DL. 2000. Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 97:591-600.
7. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA. 1990. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248:364-367.
8. Epstein LG, Gendelman HE. 1993. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechansims. Ann Neurol 33:429-436.
9. Gelbard HA, Nottet HS, Swindells S, Jett M, Dzenko KA, Genis P, White R, Wang L, Choi YB, Zhang D, Lipton SA, Tourtellotte WW, Epstein LG, Gendelman HE. 1994. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 68:4628-4635.
10. Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke DS, Skillman D, Meltzer MS. 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 167:1428-1441.
11. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, Epstein LG, Gendelman HE. 1992. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage - astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176:1703-1718.
12. Giulian D, Wendy E, Vaca K, Noonan CA. 1993. The envelope glycoprotein of human immunodeficiency virus trupe 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci USA 90:2769-2773.
13. Giulian D, Yu J, Li X, Tom D, Li J, Wendt E, Lin SN, Schwarcz R, Noonan C. 1996. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J Neurosci 16:3139-3153.
14. Glabinski AR, Ransohoff RM. 1999. Chemokines and chemokine receptors in CNS pathology. J Neurovirol 5:3-12.
15. Halstensen A, Ceska M, Brandtzaeg P, Redl H, Naess A, Waage A. 1993. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J Infect Dis 167:471-475.
16. Hesselgesser J, Horuk R. 1999. Chemokine and chemokine receptor expression in the central nervous system. J Neurovirol 5:13-26.
17. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. 1991. Structure and functional expression of a human interleukin-8 receptor. Science 253: 1278-1280.
18. Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H, Lu Z, Hesselgesser J, Perez HD, Kim J, Parker J, Hadley TJ, Peiper SC. 1997. Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158:2882-2890.
19. Hulkower K, Brosnan CF, Aquino DA, Cammer W, Kulshrestha S, Guida MP, Rapoport DA, Berman JW. 1993. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J Immunol 150:2525-2533.
20. Kalter DC, Nakamura JA, Turpin JA, Baca LM, Hoover DL, Dieffenbach C, Ralph P, Gendelman HE, Meltzer MS. 1991. Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J Immunol 146:298-307.
21. Kaul M, Lipton SA. 1999. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci USA 96:8212-8216.
22. Ketzler S, Weis S, Haug H, Budka H. 1990. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol 80:92-94.
23. Kossmann T, Stahel PF, Lenzlinger PM, Redl H, Dubs RW, Trentz O, Schlag G, Morganti-Kossmann MC. 1997. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab 17:280-289.
24. Lafrenie RM, Wahl LM, Epstein JS, Yamada KM, Dhawan S. 1997. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. J Immunol 159:4077-4083.
25. Lane BR, Lore K, Bock PJ, Andersson J, Coffey MJ, Strieter RM, Markovitz DM. 2001. Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol 75:8195-8202.
26. Licinio J, Wong ML, Gold PW. 1992. Neutrophil-activating peptide-1/interleukin-8 mRNA is localized in rat hypothalamus and hippocampus. Neuroreport 3:753-756.
27. Lipton SA, Gendelman HE. 1995. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 332:934-940.
28. Lopez-Cortes LF, Cruz-Ruiz M, Gomez-Mateos J, Viciana-Fernandez P, Martinez-Marcos FJ, Pachon J. 1995. Interleukin-8 in cerebrospinal fluid from patients with meningitis of different etiologies: its possible role as neutrophil chemotactic factor. J Infect Dis 172:581-584.
29. Malenka RC, Nicoll RA. 1999. Long-term potentiation - a decade of progress? Science 285:1870-1874.
30. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. 1992. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 32:321-329.
31. Masliah E, Ge N, Mucke L. 1996. Pathogenesis of HIV-1 associated neurodegeneration. Crit Rev Neurobiol 10:57-67.
32. Mastroianni CM, Paoletti F, Rivosecchi RM, Lancella L, Ticca F, Vullo V, Delia S. 1994. Cerebrospinal fluid interleukin 8 in children with purulent bacterial and tuberculous meningitis. Pediatr Infect Dis J 13:1008-1010.
33. Matsumoto T, Miike T, Nelson RP, Trudeau WL, Lockey RF, Yodoi J. 1993. Elevated serum levels of IL-8 in patients with HIV infection. Clin Exp Immunol 93:149-151.
34. Murphy PM, Tiffany HL. 1991. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280-1283.
35. Ostergaard C, Benfield TL, Sellebjerg F, Kronborg G, Lohse N, Lundgren JD. 1996. Interleukin-8 in cerebrospinal fluid from patients with septic and aseptic meningitis. Eur J Clin Microbiol Infect Dis 15:166-169.
36. Price RW. 1996. AIDS dementia complex: a complex, slow virus "model" of acquired genetic neurodegenerative disease. Cold Spring Harbor Symp Quant Biol 61:759-770.
37. Price RW, Brew BJ, Sidtis J, Rosenblum M, Scheck AC, Cleary P. 1988. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586-592.
38. Puma C, Danik M, Quirion R, Ramon F, Williams S. 2001. The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J Neurochem 78:960-971.
39. Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohyvk. 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7:592-600.
40. Sopper S, Demuth M, Stahl-Hennig C, Hunsmann G, Plesker R, Coulibaly C, Czub S, Ceska M, Koutsilieri E, Riederer P, Brinkmann R, Katz M, ter Meulen V. 1996. The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology 220:320-329.
41. Spanaus KS, Nadal D, Pfister HW, Seebach J, Widmer U, Frei K, Gloor S, Fontana A. 1997. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J Immunol 158:1956-1964.
42. Sprenger H, Posler A, Tonn P, Braune HJ, Huffmann G, Gemsa D. 1996. Chemokines in the cerebrospinal fluid of patients with meningitis. Clin Immunol Immunopathol 80:155-161.
43. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L. 1994. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice [see comments]. Nature 367:188-193.
44. Van Meir E, Ceska M, Effenberger F, Walz A, Grouzmann E, Desbaillets I, Frei K, Fontana A, de Tribolet N. 1992. Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 52:4297-4305.
45. Vazeux R, Lacroix-Ciaudo C, Blanche S, Cumont MC, Henin D, Gray F, Boccon-Gibod L, Tardieu M. 1992. Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am J Pathol 140:137-144.
46. Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Harel-Bellan A, Farrar WL. 1989. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin-1. Proc Natl Acad Sci USA 86:621-625.
47. Xia M, Qin S, McNamara M, Mackay C, Hyman BT. 1997. Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Am J Pathol 150:1267-1274.
48. Xiong H, Baskys A, Wojtowicz JM. 1996. Brain-derived peptides inhibit synaptic transmission via presynaptic GABAB receptors in CA1 area of rat hippocampal slices. Brain Res 737:188-194.
49. Xiong H, Zheng J, Thylin M, Gendelman HE. 1999a. Unraveling the mechanisms of neurotoxicity in HIV type 1-associated dementia: inhibition of neuronal synaptic transmission by macrophage secretory products. AIDS Res Hum Retroviruses 15:57-63.
50. Xiong H, Zeng YC, Zheng J, Thylin M, Gendelman HE. 1999b. Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: a mechanism for cognitive dysfunction in HIV-1-associated dementia. J Neurovirol 5:519-528.
51. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ. 1987. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). J Immunol 139:788-793.
52. Zheng J, Bauer M, Williams C, Niemann D, Peng H, Ghorpade A, Gendelman HE, Cotter C. 2001. Interleukin-8 and growth related oncogene-alpha effect neuronal signalling and demise in HIV-1-associated dementia. J Neuroimmunol 118:125.